声明
摘要
1 前言
2 抗gp210和抗sp100在原发性胆汁性肝硬化中的诊断价值
2.1 材料与方法
2.1.1 研究对象
2.1.2 统计学处理
2.2 结果
2.2.1 抗gp210和抗sp100的分布
2.2.2 抗gp210和抗sp100在其他患者中的分布
2.2.3 抗gp210和抗sp100对PBC的诊断效率
2.2.4 抗gp210和抗sp100阳性患者的ANA核型
2.3 讨论
3 抗gp210阳性原发性胆汁性肝硬化患者的临床特征
3.1 材料与方法
3.1.1 研究对象
3.1.2 研究方法
3.1.3 统计学处理
3.2 结果
3.2.1 抗gp210阳性的PBC
3.2.2 抗gp210阳性且抗线粒体抗体阴性的PBC
3.2.3 Child-Pugh评分,MELD评分和Mayo风险评分
3.3 讨论
4 抗sp100阳性原发性胆汁性肝硬化患者的临床特征
4.1 材料与方法
4.2 结果
4.2.1 抗sp100阳性的PBC
4.2.2 抗sp100阳性且抗线粒体抗体阴性的PBC
4.2.3 Child-Pugh评分,MELD评分和Mayo风险评分
4.3 讨论
5 结论
1.Preface
2.Diagnostic Value of Anti-sp100 and Anti-gp210 in Primary Biliary Cirrhosis
2.1 Materials and Methods
2.1.1 Patients
2.1.2 Methods
2.1.3 Statistical analysis
2.2 Results
2.2.1 The distribution of anti-gp210 and anti-sp100 in study population
2.2.2 The prevalence of anti-gp210 and anti-sp100 in other patients
2.2.3 The diagnostic value of anti-gp210 and anti-sp100 for PBC
2.2.4 The ANA patterns of anti-gp210 and anti-sp100 positive PBC patients
2.3 Discussion
3.Clinical Characteristics of Anti-gp210 Positive Primary Biliary Cirrhosis
3.1 Materials and Methods
3.1.1 Patients
3.1.2 Methods
3.1.3 Statistical analysis
3.2 Results
3.2.1 Anti-gp210 positive PBC
3.2.2 AMA negative and anti-gp210 positive PBC patients
3.2.3 Child-Pugh,MELD and Mayo risk score
3.3 Discussion
4.Clinical Characteristics of Anti-sp100 Positive Primary Biliary Cirrhosis
4.1 Materials and Methods
4.2 Results
4.2.1 Anti-sp100 positive PBC
4.2.2 AMA negative and anti-gp210 positive PBC patients
4.2.3 Child-Pugh,MELD and Mayo risk score
4.3 Discussion
5.Conclusion
参考文献
附录
致谢
攻读学位期间发表的学术论文
上海交通大学;